Hematology

The CGTLive™ Hematology specialty topic page houses the most up-to-date clinical news coverage in the field of hematology gene and cell therapy. It also includes video interviews with key opinion leaders in the field of hematology/oncology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various blood disorders.

Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – April 11, 2025

April 11th 2025

Review top news and interview highlights from the week ending April 11, 2025.

Around the Helix: Cell and Gene Therapy Company Updates – April 9, 2025
Around the Helix: Cell and Gene Therapy Company Updates – April 9, 2025

April 9th 2025

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – April 4, 2025

April 4th 2025

Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025
Around the Helix: Cell and Gene Therapy Company Updates – April 2, 2025

April 2nd 2025

FDA Activity Recap: March 2025 Features FDA Approvals in Hemophilia, ATTR Amyloidosis, and More
FDA Activity Recap: March 2025 Features FDA Approvals in Hemophilia, ATTR Amyloidosis, and More

April 1st 2025

Video Interviews
Podcasts
ImmunoLogic
ImmunoLogic
ImmunoLogic
ImmunoLogic
Latest CME Events & Activities

Integrating the Latest Algorithms for Prophylaxis and Treatment of Acute and Chronic GvHD: How the Experts Think and Treat

View More

Upstate New York Hematology & Hematologic Oncology Conference: A Review of the 66th ASH Annual Meeting

April 26-27, 2025

Register Now!

29th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma

View More

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

View More

28th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

View More

New Combination-Based Approaches to Newly Diagnosed MM: What Do the Data, the Experts, and Patients Say?

View More

Medical Crossfire®: Onco-Nurses Exchange Best Practices on PNH Treatment and Symptom Management Along the Patient Care Journey

View More

Show Me Your Care Plan™: How Can Onco-Nurses Improve Patient Care in CML Across the Treatment Continuum?

View More

Show Me Your Care Plan! Managing Breast Cancer Patients Under Current Data for Immuno- and Targeted Therapies, CDK4/6i, ADCs and Beyond

View More

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

View More

Medical Crossfire™: Integrating Recent Evidence into the Treatment of Newly Diagnosed Multiple Myeloma

June 12, 2025

Register Now!

Broadening Horizons in Newly Diagnosed Multiple Myeloma—Exploring New Combination Approaches and Their Impact

View More

Medical Crossfire®: Risk-Adapted Management of Multiple Myeloma—How Do the Experts Do It?

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

9th Annual Live Medical Crossfire®: Hematologic Malignancies

July 26, 2025

Register Now!

Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals

View More

Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options

View More

New Horizons in Multiple Myeloma Treatment – Selection and Sequencing From Newly Diagnosed to Relapsed/Refractory Disease

View More

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

View More

Medical Crossfire®: Uncovering The Clinical Utility of Combination Therapies and MRD Assessment in Newly Diagnosed Multiple Myeloma

View More

Community Practice Connections™: 8th Annual School of Nursing Oncology™

View More

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

View More

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

View More

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

View More

Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice

View More

Rounds with Dr Jabbour: Breaking Barriers in ALL Treatment

View More

How We Do It®: New Combinations Reshaping Treatment Decision-Making in Newly Diagnosed Multiple Myeloma

View More

More News

© 2025 MJH Life Sciences

All rights reserved.